Belkyra®產品簡介
隨着年紀增長、體重增加、甚至遺傳因素都容易出現的雙下巴問題,即使努力做運動瘦身,甚至節食減肥,都未必能有效改善積聚於下巴的脂肪。
Belkyra®永久溶脂療程在外國早已盛行,去年終於登陸香港,亦是唯一獲得美國FDA及歐洲EMA雙認可,能針對消除雙下巴脂肪的醫學美容療程,對於飽受雙下巴困擾的女士而言絕對是天大的好消息!
資料由客戶提供。
References: 1. Medical Insight, Inc. 2018. Global Facial Injectables Market Study. December 2018. Based on worldwide neurotoxins and dermal filler market 2017 (in sales value). 2. Allergan reaches historic BOTOX® milestone with 100 million vials, Aesthetic Medicine, 16 April 2019. https://aestheticmed.co.uk/site/industrynewsdetails/allergan-reaches-historic-botox-milestone-with-100-million-vials 3. Beer KR et al. J Drugs Dermatol 2011;10:39–44; 4. Allergan. Data on File. INT-JUV-2150030. Fillers Global Number of Syringes by December 2020. Mar 2021; 5. Philipp-Dormston WG et al. J Cosmet Laser Ther. 2014;16:171-9; 6. Callan P, et al. Clin Cosmet Investig Dermatol. 2013;6:81-9; 7. Ogilvie P et al. Aesthet Surg J. 2020 Aug 14;40(9):NP499-NP510.
<div class="RelatedLinks FontRobotod" data-v-796a6bfe="" data-v-e9e45894="" style="-webkit-tap-highlight-color: rgba(0, 0, 0, 0); box-sizing: border-box; font-family: Roboto, " open="" sans",="" "microsoft="" yahei",="" jhenghei",="" sans-serif;="" margin:="" 0px="" 50px;="" color:="" rgb(0,="" 0,="" 0);="" font-size:="" 14px;="" background-color:="" rgb(244,="" 243,="" 239);"="">